Explore the issues of interest at different stages of the treatment process for patients with EGFR‐mutated non‐small cell lung cancer with brain metastasis during the first‐line EGFR‐TKIs treatment and the subsequent therapy after the failure of EGFR‐TKIs. Here, EGFR is linked to lung cancer.